
US Patent No: 6,358,539
Number of patents in Portfolio can not be more than 2000
Pharmaceutical compositions for reducing the appearance of cellulite
Stats
-
Mar 19, 2002
Issued date -
Aug 18, 2000
filing date -
09/641,376
serial no -
In Force
status
Importance
Abstract
Compositions and methods for reducing or eliminating the appearance of cellulite. The method involves administering to a patient in need of treatment therapeutically effective amounts of a sugar compound that is converted to a glycosaminoglycan in the patient in an amount sufficient to thicken the skin, a primary antioxidant component in an amount sufficient to substantially inhibit the formation of collagenase and elastase, at least one amino acid component in an amount sufficient to assist in the thickening of the skin, and at least one transition metal component in an amount effective to bind collagen and elastic fibers and thicken skin so as to reduce or eliminate the appearance of cellulite. A preferred method of treatment further includes administering the components above in conjunction with a vascular dilator to improve blood supply to the skin and/or a fat burner to reduce absorption or digestion of fat in the digestive tract or to prevent the production of fat. The compositions and methods may optionally include chromium picolinate to facilitate entry of sugar into cells to improve fat metabolism. In one embodiment, these methods encompass administering the amounts as a pharmaceutical composition.
First Claim
Related Publications
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 4,647,453 Treatment for tissue degenerative inflammatory disease | 57 | 1985 | |
| 4,938,969 Method for the treatment of aging or photo-damaged skin | 41 | 1988 | |
|
|
|||
| 5,308,627 Nutritional supplement for optimizing cellular health | 35 | 1992 | |
| 5,332,579 Nutritional supplement for optimizing cellular health | 46 | 1992 | |
|
|
|||
| 5,364,845 Glucosamine, chondroitin and manganese composition for the protection and repair of connective tissue | 54 | 1993 | |
| 5,587,363 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue | 57 | 1994 | |
|
|
|||
| 5,962,482 Method of reducing cellulite in mamalian skin | 7 | 1999 | |
| 6,093,411 Compositions for regulating skin appearance | 21 | 1999 | |
|
|
|||
| 5,162,303 Pharmaceutical compositions containing prolactin and methods for the use thereof | 9 | 1990 | |
|
|
|||
| 6,156,347 Controlled release chromium picolinate | 3 | 1998 | |
|
|
|||
| 5,153,174 Polymer mixtures useful in skin care | 34 | 1989 | |
|
|
|||
| 5,529,769 Cosmetic compositions containing betulinic acid | 27 | 1994 | |
|
|
|||
| 4,285,964 Salts of (+)-catechine, their preparation and use, and compositions containing these salts | 9 | 1979 | |
|
|
|||
| 5,730,988 Nutritional supplements for improving glucose metabolism | 28 | 1997 | |
|
|
|||
| 5,198,465 Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen | 31 | 1991 | |
|
|
|||
| 4,518,614 Cosmetic preparation | 15 | 1983 | |
|
|
|||
| 4,642,340 Stable compounds of glucosamine sulphate | 23 | 1982 | |
|
|
|||
| 4,716,224 Crosslinked hyaluronic acid and its use | 73 | 1985 | |
|
|
|||
| 5,371,089 Method and composition for ameliorating the adverse effects of aging | 15 | 1994 | |
|
|
|||
| 5,415,875 Anti-peroxide external preparation for skin | 17 | 1993 | |
|
|
|||
| 4,956,173 Composition and use of ademetionine against ageing of the skin | 16 | 1988 | |
|
|
|||
| 5,296,500 Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy | 35 | 1993 | |
|
|
|||
| 4,486,416 Protection of human and animal cells subject to exposure to trauma | 36 | 1981 | |
|
|
|||
| 4,414,202 Composition for treatment of wounds | 36 | 1981 | |
|
|
|||
| 4,424,232 Treatment of herpes simplex | 20 | 1982 | |
| 5,281,196 Skin treatment composition and method of use | 18 | 1992 | |
| 6,147,054 Composition for cosmetic, pharmaceutical or dietetic use based on an amino sugar and/or a polyhydroxylic acid | 23 | 1997 | |
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Sep 19, 2013 |
| Fee | Large entity fee | small entity fee | micro entity fee |
|---|---|---|---|
| Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
| Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |